Cargando…

Insulin resistance limits corneal nerve regeneration in patients with type 2 diabetes undergoing intensive glycemic control

AIMS/INTRODUCTION: This study aimed to investigate whether insulin resistance (IR) in individuals with type 2 diabetes undergoing intensive glycemic control determines the extent of improvement in neuropathy. MATERIALS AND METHODS: This was an exploratory substudy of an open‐label, randomized contro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ponirakis, Georgios, Abdul‐Ghani, Muhammad A, Jayyousi, Amin, Zirie, Mahmoud A, Al‐Mohannadi, Salma, Almuhannadi, Hamad, Petropoulos, Ioannis N, Khan, Adnan, Gad, Hoda, Migahid, Osama, Megahed, Ayman, Qazi, Murtaza, AlMarri, Fatema, Al‐Khayat, Fatima, Mahfoud, Ziyad, DeFronzo, Ralph, Malik, Rayaz A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8565403/ https://www.ncbi.nlm.nih.gov/pubmed/34002953 http://dx.doi.org/10.1111/jdi.13582

Ejemplares similares

Painful diabetic neuropathy is associated with increased nerve regeneration in patients with type 2 diabetes undergoing intensive glycemic control
por: Ponirakis, Georgios, et al.
Publicado: (2021)

Effect of treatment with exenatide and pioglitazone or basal-bolus insulin on diabetic neuropathy: a substudy of the Qatar Study
por: Ponirakis, Georgios, et al.
Publicado: (2020)

Association of Cerebral Ischemia With Corneal Nerve Loss and Brain Atrophy in MCI and Dementia
por: Ponirakis, Georgios, et al.
Publicado: (2021)

Glycated hemoglobin versus oral glucose tolerance test in the identification of subjects with prediabetes in Qatari population
por: Iskandar, Saadallah, et al.
Publicado: (2019)

Combination Therapy With Exenatide Plus Pioglitazone Versus Basal/Bolus Insulin in Patients With Poorly Controlled Type 2 Diabetes on Sulfonylurea Plus Metformin: The Qatar Study
por: Abdul-Ghani, Muhammad, et al.
Publicado: (2017)

Erratum. Combination Therapy With Exenatide Plus Pioglitazone Versus Basal/Bolus Insulin in Patients With Poorly Controlled Type 2 Diabetes on Sulfonylurea Plus Metformin: The Qatar Study. Diabetes Care 2017;40:325–331
por: Abdul-Ghani, Muhammad, et al.
Publicado: (2017)

Diagnosing Diabetic Neuropathy: Something Old, Something New
por: Petropoulos, Ioannis N., et al.
Publicado: (2018)

Progressive loss of corneal nerve fibers is associated with physical inactivity and glucose lowering medication associated with weight gain in type 2 diabetes
por: Ponirakis, Georgios, et al.
Publicado: (2022)

Prevalence and risk factors for diabetic peripheral neuropathy, neuropathic pain and foot ulceration in the Arabian Gulf region
por: Ponirakis, Georgios, et al.
Publicado: (2022)

Prevalence and risk factors for diabetic neuropathy and painful diabetic neuropathy in primary and secondary healthcare in Qatar
por: Ponirakis, Georgios, et al.
Publicado: (2020)

Association of corneal nerve fiber measures with cognitive function in dementia
por: Ponirakis, Georgios, et al.
Publicado: (2019)

Prevalence of obesity among hypertensive patients in Primary Care Clinic, Security Forces Hospital, Riyadh, Saudi Arabia 2017–2018: A prospective cross-sectional study
por: AlMarri, Eman A., et al.
Publicado: (2020)

Loss of corneal nerves and brain volume in mild cognitive impairment and dementia
por: Ponirakis, Georgios, et al.
Publicado: (2022)

Corneal confocal microscopy identifies greater corneal nerve damage in patients with a recurrent compared to first ischemic stroke
por: Khan, Adnan, et al.
Publicado: (2020)

Corneal Nerve and Brain Imaging in Mild Cognitive Impairment and Dementia
por: Al-Janahi, Eiman, et al.
Publicado: (2020)

Corneal confocal microscopy for the diagnosis of diabetic peripheral neuropathy: A systematic review and meta‐analysis
por: Gad, Hoda, et al.
Publicado: (2021)

Prevalence and risk factors for painful diabetic neuropathy in secondary healthcare in Qatar
por: Ponirakis, Georgios, et al.
Publicado: (2019)

Corneal confocal microscopy demonstrates sensory nerve loss in children with autism spectrum disorder
por: Khan, Adnan, et al.
Publicado: (2023)

T13. CORNEAL CONFOCAL MICROSCOPY DETECTS NEURAL CHANGES IN SCHIZOPHRENIA
por: Woodruff, Peter, et al.
Publicado: (2020)

Abnormal corneal nerve morphology and brain volume in patients with schizophrenia
por: Ponirakis, Georgios, et al.
Publicado: (2022)

Diagnosing and managing diabetic somatic and autonomic neuropathy
por: Azmi, Shazli, et al.
Publicado: (2019)

Artificial Intelligence–Based Classification of Diabetic Peripheral Neuropathy From Corneal Confocal Microscopy Images
por: Salahouddin, Tooba, et al.
Publicado: (2021)

Risk Factors for Microvascular Complications of Diabetes in a High-Risk Middle East Population
por: Cheema, Sohaila, et al.
Publicado: (2018)

Corneal nerve loss predicts dementia in patients with mild cognitive impairment
por: Ponirakis, Georgios, et al.
Publicado: (2023)

Type 2 Diabetes Can Be Prevented With Early Pharmacological Intervention
por: DeFronzo, Ralph A., et al.
Publicado: (2011)

Is It Time to Change the Type 2 Diabetes Treatment Paradigm? Yes! GLP-1 RAs Should Replace Metformin in the Type 2 Diabetes Algorithm
por: Abdul-Ghani, Muhammad, et al.
Publicado: (2017)

Corneal immune cells as a biomarker of inflammation in multiple sclerosis: a longitudinal study
por: Petropoulos, Ioannis N., et al.
Publicado: (2023)

Pathogenesis of Insulin Resistance in Skeletal Muscle
por: Abdul-Ghani, Muhammad A., et al.
Publicado: (2010)

Plasma Glucose Concentration and Prediction of Future Risk of Type 2 Diabetes
por: Abdul-Ghani, Muhammad A., et al.
Publicado: (2009)

Corneal axonal loss as an imaging biomarker of neurodegeneration in multiple sclerosis: a longitudinal study
por: Petropoulos, Ioannis N., et al.
Publicado: (2023)

In Vivo Actions of Peroxisome Proliferator–Activated Receptors: Glycemic control, insulin sensitivity, and insulin secretion
por: Eldor, Roy, et al.
Publicado: (2013)

Pathophysiologic Approach to Therapy in Patients With Newly Diagnosed Type 2 Diabetes
por: DeFronzo, Ralph A., et al.
Publicado: (2013)

Novel Hypothesis to Explain Why SGLT2 Inhibitors Inhibit Only 30–50% of Filtered Glucose Load in Humans
por: Abdul-Ghani, Muhammad A., et al.
Publicado: (2013)

Hypertension Contributes to Neuropathy in Patients With Type 1 Diabetes
por: Ponirakis, Georgios, et al.
Publicado: (2019)

One-Hour Plasma Glucose Concentration and the Metabolic Syndrome Identify Subjects at High Risk for Future Type 2 Diabetes
por: Abdul-Ghani, Muhammad A., et al.
Publicado: (2008)

Corneal nerve and endothelial cell damage in patients with transient ischemic attack and minor ischemic stroke
por: Gad, Hoda, et al.
Publicado: (2019)

Correction: Corneal nerve and endothelial cell damage in patients with transient ischemic attack and minor ischemic stroke
por: Gad, Hoda, et al.
Publicado: (2019)

Corneal nerve loss as a surrogate marker for poor pial collaterals in patients with acute ischemic stroke
por: Khan, Adnan, et al.
Publicado: (2021)

Continuous glucose monitoring reveals a novel association between duration and severity of hypoglycemia, and small nerve fiber injury in patients with diabetes
por: Gad, Hoda, et al.
Publicado: (2022)

Corneal Confocal Microscopy detects a Reduction in Corneal Endothelial Cells and Nerve Fibres in Patients with Acute Ischemic Stroke
por: Khan, Adnan, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_7j6ema8itq4hnrcsdta611j1gl